Sign in

CIK 0001764013 · Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
832771572
Phone
917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
  1. 424B5 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. UPLOAD Other SEC-generated Letter
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 424B5 Offering Prospectus
  9. UPLOAD Other SEC-generated Letter
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. UPLOAD Other SEC-generated Letter
  12. 424B7 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. 424B3 Offering Prospectus
  18. 424B4 Offering Prospectus
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 3 · 51 filings